1 completed, 1 recruiting. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow azeliragon: new trials by email Literature Review of azeliragon trials Research Report on azeliragon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma Azeliragon, Temozolomide, Radiation therapy - Glioblastoma | Early Phase 1 | Recruiting | Washington University School of Medicine | 12 | 2025-11-06 | 2026-05-29 |
| Mechanisms of Pain Hypersensitivity in a Human Skin Inflammation Model Synthetic interstitial fluid (SIF) / SIF neutral pH, Synthetic interstitial fluid (SIF) / SIF acidic pH, Synthetic interstitial fluid (SIF) / SIF acidic pH + BCTC 1 µM - Pain | Early Phase 1 | Completed | Stefan Heber | 42 | 2025-06-17 | 2025-07-29 |
Glioblastoma (1) · Hyperalgesia (1) · Inflammation (1) · Pain (1)
Stefan Heber (1) · Washington University School of Medicine (1)
Austria (1) · United States (1)
PMID 10191237, PMID 18299127, PMID 20562702, PMID 21270403, PMID 28062311, PMID 30782041, PMID 32107360, PMID 33548580, PMID 33863932, PMID 34293819, PMID 34935141, PMID 42830319, PMID 5781321